1. Home
  2. CLRO vs NDRA Comparison

CLRO vs NDRA Comparison

Compare CLRO & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ClearOne Inc. (DE)

CLRO

ClearOne Inc. (DE)

SELL

Current Price

$4.76

Market Cap

8.7M

Sector

Technology

ML Signal

SELL

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

SELL

Current Price

$4.42

Market Cap

7.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CLRO
NDRA
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
7.4M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
CLRO
NDRA
Price
$4.76
$4.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.4M
8.1K
Earning Date
11-10-2026
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 84.32
EPS
★ N/A
N/A
Revenue
★ $46,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 11.59
N/A
52 Week Low
$1.62
$2.96
52 Week High
$16.50
$6.80

Technical Indicators

Market Signals
Indicator
CLRO
NDRA
Relative Strength Index (RSI) 53.90 36.38
Support Level $3.32 $4.13
Resistance Level $5.91 $5.24
Average True Range (ATR) 0.87 0.31
MACD -0.05 -0.01
Stochastic Oscillator 37.91 35.44

Price Performance

Historical Comparison
CLRO
NDRA

About CLRO ClearOne Inc. (DE)

ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

Share on Social Networks: